Global Subcutaneous Immunotherapy Market Growth (Status and Outlook) 2025-2031

September 2025 | 87 pages | ID: G203A1438DCEN
LP Information

Abstracts

According to this study, the global Subcutaneous Immunotherapy market size will reach US$ million by 2031.

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.

United States market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Subcutaneous Immunotherapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Subcutaneous Immunotherapy players cover Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Subcutaneous Immunotherapy Industry Forecast” looks at past sales and reviews total world Subcutaneous Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Subcutaneous Immunotherapy sales for 2025 through 2031. With Subcutaneous Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Immunotherapy industry.

This Insight Report provides a comprehensive analysis of the global Subcutaneous Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Subcutaneous Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Subcutaneous Immunotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Immunotherapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Asthma
• Allergic Rhinitis
• Venom Allergy
• Food Allergy

Segmentation by Application:

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Anergis
• HAL Allergy Group
• Merck
• Allergy Therapeutics
• ALK-Abello
• Stallergenes Greer
• Laboratorios LETI

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Subcutaneous Immunotherapy Market Size (2020-2031)
  2.1.2 Subcutaneous Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Subcutaneous Immunotherapy by Country/Region (2020, 2024 & 2031)
2.2 Subcutaneous Immunotherapy Segment by Type
  2.2.1 Asthma
  2.2.2 Allergic Rhinitis
  2.2.3 Venom Allergy
  2.2.4 Food Allergy
2.3 Subcutaneous Immunotherapy Market Size by Type
  2.3.1 Subcutaneous Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
2.4 Subcutaneous Immunotherapy Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Online Pharmacies
  2.4.3 Retail Pharmacies
2.5 Subcutaneous Immunotherapy Market Size by Application
  2.5.1 Subcutaneous Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)

3 SUBCUTANEOUS IMMUNOTHERAPY MARKET SIZE BY PLAYER

3.1 Subcutaneous Immunotherapy Market Size Market Share by Player
  3.1.1 Global Subcutaneous Immunotherapy Revenue by Player (2020-2025)
  3.1.2 Global Subcutaneous Immunotherapy Revenue Market Share by Player (2020-2025)
3.2 Global Subcutaneous Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SUBCUTANEOUS IMMUNOTHERAPY BY REGION

4.1 Subcutaneous Immunotherapy Market Size by Region (2020-2025)
4.2 Global Subcutaneous Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Subcutaneous Immunotherapy Market Size Growth (2020-2025)
4.4 APAC Subcutaneous Immunotherapy Market Size Growth (2020-2025)
4.5 Europe Subcutaneous Immunotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Subcutaneous Immunotherapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Subcutaneous Immunotherapy Market Size by Country (2020-2025)
5.2 Americas Subcutaneous Immunotherapy Market Size by Type (2020-2025)
5.3 Americas Subcutaneous Immunotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Subcutaneous Immunotherapy Market Size by Region (2020-2025)
6.2 APAC Subcutaneous Immunotherapy Market Size by Type (2020-2025)
6.3 APAC Subcutaneous Immunotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Subcutaneous Immunotherapy Market Size by Country (2020-2025)
7.2 Europe Subcutaneous Immunotherapy Market Size by Type (2020-2025)
7.3 Europe Subcutaneous Immunotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Subcutaneous Immunotherapy by Region (2020-2025)
8.2 Middle East & Africa Subcutaneous Immunotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Subcutaneous Immunotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SUBCUTANEOUS IMMUNOTHERAPY MARKET FORECAST

10.1 Global Subcutaneous Immunotherapy Forecast by Region (2026-2031)
  10.1.1 Global Subcutaneous Immunotherapy Forecast by Region (2026-2031)
  10.1.2 Americas Subcutaneous Immunotherapy Forecast
  10.1.3 APAC Subcutaneous Immunotherapy Forecast
  10.1.4 Europe Subcutaneous Immunotherapy Forecast
  10.1.5 Middle East & Africa Subcutaneous Immunotherapy Forecast
10.2 Americas Subcutaneous Immunotherapy Forecast by Country (2026-2031)
  10.2.1 United States Market Subcutaneous Immunotherapy Forecast
  10.2.2 Canada Market Subcutaneous Immunotherapy Forecast
  10.2.3 Mexico Market Subcutaneous Immunotherapy Forecast
  10.2.4 Brazil Market Subcutaneous Immunotherapy Forecast
10.3 APAC Subcutaneous Immunotherapy Forecast by Region (2026-2031)
  10.3.1 China Subcutaneous Immunotherapy Market Forecast
  10.3.2 Japan Market Subcutaneous Immunotherapy Forecast
  10.3.3 Korea Market Subcutaneous Immunotherapy Forecast
  10.3.4 Southeast Asia Market Subcutaneous Immunotherapy Forecast
  10.3.5 India Market Subcutaneous Immunotherapy Forecast
  10.3.6 Australia Market Subcutaneous Immunotherapy Forecast
10.4 Europe Subcutaneous Immunotherapy Forecast by Country (2026-2031)
  10.4.1 Germany Market Subcutaneous Immunotherapy Forecast
  10.4.2 France Market Subcutaneous Immunotherapy Forecast
  10.4.3 UK Market Subcutaneous Immunotherapy Forecast
  10.4.4 Italy Market Subcutaneous Immunotherapy Forecast
  10.4.5 Russia Market Subcutaneous Immunotherapy Forecast
10.5 Middle East & Africa Subcutaneous Immunotherapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Subcutaneous Immunotherapy Forecast
  10.5.2 South Africa Market Subcutaneous Immunotherapy Forecast
  10.5.3 Israel Market Subcutaneous Immunotherapy Forecast
  10.5.4 Turkey Market Subcutaneous Immunotherapy Forecast
10.6 Global Subcutaneous Immunotherapy Forecast by Type (2026-2031)
10.7 Global Subcutaneous Immunotherapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Subcutaneous Immunotherapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Anergis
  11.1.1 Anergis Company Information
  11.1.2 Anergis Subcutaneous Immunotherapy Product Offered
  11.1.3 Anergis Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Anergis Main Business Overview
  11.1.5 Anergis Latest Developments
11.2 HAL Allergy Group
  11.2.1 HAL Allergy Group Company Information
  11.2.2 HAL Allergy Group Subcutaneous Immunotherapy Product Offered
  11.2.3 HAL Allergy Group Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 HAL Allergy Group Main Business Overview
  11.2.5 HAL Allergy Group Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Subcutaneous Immunotherapy Product Offered
  11.3.3 Merck Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 Allergy Therapeutics
  11.4.1 Allergy Therapeutics Company Information
  11.4.2 Allergy Therapeutics Subcutaneous Immunotherapy Product Offered
  11.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Allergy Therapeutics Main Business Overview
  11.4.5 Allergy Therapeutics Latest Developments
11.5 ALK-Abello
  11.5.1 ALK-Abello Company Information
  11.5.2 ALK-Abello Subcutaneous Immunotherapy Product Offered
  11.5.3 ALK-Abello Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 ALK-Abello Main Business Overview
  11.5.5 ALK-Abello Latest Developments
11.6 Stallergenes Greer
  11.6.1 Stallergenes Greer Company Information
  11.6.2 Stallergenes Greer Subcutaneous Immunotherapy Product Offered
  11.6.3 Stallergenes Greer Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Stallergenes Greer Main Business Overview
  11.6.5 Stallergenes Greer Latest Developments
11.7 Laboratorios LETI
  11.7.1 Laboratorios LETI Company Information
  11.7.2 Laboratorios LETI Subcutaneous Immunotherapy Product Offered
  11.7.3 Laboratorios LETI Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Laboratorios LETI Main Business Overview
  11.7.5 Laboratorios LETI Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Subcutaneous Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Subcutaneous Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Asthma
Table 4. Major Players of Allergic Rhinitis
Table 5. Major Players of Venom Allergy
Table 6. Major Players of Food Allergy
Table 7. Subcutaneous Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Subcutaneous Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
Table 10. Subcutaneous Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Subcutaneous Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)
Table 13. Global Subcutaneous Immunotherapy Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Subcutaneous Immunotherapy Revenue Market Share by Player (2020-2025)
Table 15. Subcutaneous Immunotherapy Key Players Head office and Products Offered
Table 16. Subcutaneous Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Subcutaneous Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Subcutaneous Immunotherapy Market Size Market Share by Region (2020-2025)
Table 21. Global Subcutaneous Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Subcutaneous Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Subcutaneous Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Subcutaneous Immunotherapy Market Size Market Share by Country (2020-2025)
Table 25. Americas Subcutaneous Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
Table 27. Americas Subcutaneous Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)
Table 29. APAC Subcutaneous Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Subcutaneous Immunotherapy Market Size Market Share by Region (2020-2025)
Table 31. APAC Subcutaneous Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Subcutaneous Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Subcutaneous Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Subcutaneous Immunotherapy Market Size Market Share by Country (2020-2025)
Table 35. Europe Subcutaneous Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Subcutaneous Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Subcutaneous Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Subcutaneous Immunotherapy Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Subcutaneous Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Subcutaneous Immunotherapy
Table 41. Key Market Challenges & Risks of Subcutaneous Immunotherapy
Table 42. Key Industry Trends of Subcutaneous Immunotherapy
Table 43. Global Subcutaneous Immunotherapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Subcutaneous Immunotherapy Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Subcutaneous Immunotherapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Subcutaneous Immunotherapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Anergis Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 48. Anergis Subcutaneous Immunotherapy Product Offered
Table 49. Anergis Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Anergis Main Business
Table 51. Anergis Latest Developments
Table 52. HAL Allergy Group Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 53. HAL Allergy Group Subcutaneous Immunotherapy Product Offered
Table 54. HAL Allergy Group Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. HAL Allergy Group Main Business
Table 56. HAL Allergy Group Latest Developments
Table 57. Merck Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 58. Merck Subcutaneous Immunotherapy Product Offered
Table 59. Merck Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Merck Main Business
Table 61. Merck Latest Developments
Table 62. Allergy Therapeutics Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 63. Allergy Therapeutics Subcutaneous Immunotherapy Product Offered
Table 64. Allergy Therapeutics Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Allergy Therapeutics Main Business
Table 66. Allergy Therapeutics Latest Developments
Table 67. ALK-Abello Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 68. ALK-Abello Subcutaneous Immunotherapy Product Offered
Table 69. ALK-Abello Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. ALK-Abello Main Business
Table 71. ALK-Abello Latest Developments
Table 72. Stallergenes Greer Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 73. Stallergenes Greer Subcutaneous Immunotherapy Product Offered
Table 74. Stallergenes Greer Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Stallergenes Greer Main Business
Table 76. Stallergenes Greer Latest Developments
Table 77. Laboratorios LETI Details, Company Type, Subcutaneous Immunotherapy Area Served and Its Competitors
Table 78. Laboratorios LETI Subcutaneous Immunotherapy Product Offered
Table 79. Laboratorios LETI Subcutaneous Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Laboratorios LETI Main Business
Table 81. Laboratorios LETI Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Subcutaneous Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Subcutaneous Immunotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Subcutaneous Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Subcutaneous Immunotherapy Sales Market Share by Country/Region (2024)
Figure 8. Subcutaneous Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Subcutaneous Immunotherapy Market Size Market Share by Type in 2024
Figure 10. Subcutaneous Immunotherapy in Hospital Pharmacies
Figure 11. Global Subcutaneous Immunotherapy Market: Hospital Pharmacies (2020-2025) & ($ millions)
Figure 12. Subcutaneous Immunotherapy in Online Pharmacies
Figure 13. Global Subcutaneous Immunotherapy Market: Online Pharmacies (2020-2025) & ($ millions)
Figure 14. Subcutaneous Immunotherapy in Retail Pharmacies
Figure 15. Global Subcutaneous Immunotherapy Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 16. Global Subcutaneous Immunotherapy Market Size Market Share by Application in 2024
Figure 17. Global Subcutaneous Immunotherapy Revenue Market Share by Player in 2024
Figure 18. Global Subcutaneous Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas Subcutaneous Immunotherapy Market Size 2020-2025 ($ millions)
Figure 20. APAC Subcutaneous Immunotherapy Market Size 2020-2025 ($ millions)
Figure 21. Europe Subcutaneous Immunotherapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Subcutaneous Immunotherapy Market Size 2020-2025 ($ millions)
Figure 23. Americas Subcutaneous Immunotherapy Value Market Share by Country in 2024
Figure 24. United States Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Subcutaneous Immunotherapy Market Size Market Share by Region in 2024
Figure 29. APAC Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 30. APAC Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 31. China Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Subcutaneous Immunotherapy Market Size Market Share by Country in 2024
Figure 38. Europe Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 39. Europe Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. France Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Subcutaneous Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Subcutaneous Immunotherapy Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Subcutaneous Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Subcutaneous Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 54. APAC Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 55. Europe Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 57. United States Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 58. Canada Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 61. China Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 62. Japan Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 63. Korea Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 65. India Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 66. Australia Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 67. Germany Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 68. France Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 69. UK Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 70. Italy Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 71. Russia Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 74. Israel Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 75. Turkey Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)
Figure 76. Global Subcutaneous Immunotherapy Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Subcutaneous Immunotherapy Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Subcutaneous Immunotherapy Market Size 2026-2031 ($ millions)